Study guide

17.2 Epilepsy Syndromes & Status Epilepticus

Arab Board Pediatrics Part 1 Written Examination ABHS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy

2 Neonatal Care I

2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia

3 Neonatal Care II

3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening

4 Infectious Diseases

4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections

5 Immunization

5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations

6 Allergy & Immunology

6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy

7 Growth & Development

7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders

8 Nutrition

8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)

9 Pediatric Emergencies I

9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology

10 Pediatric Emergencies II

10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding

11 Cardiology

11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease

12 Respiratory

12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders

13 Gastroenterology

13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia

14 Nephrology & Genitourinary

14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies

15 Hematology & Oncology

15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency

16 Endocrinology

16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty

17 Neurology

17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache

18 Genetics, Dysmorphology & Metabolism

18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism

19 Fluids, Electrolytes & Pharmacology

19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing

20 Dermatology, ENT, Ophthalmology & Musculoskeletal

20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders

21 Adolescent Medicine & Ethics

21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics

22 Final Review & Exam Strategy

22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management

17.2 Epilepsy Syndromes & Status Epilepticus

Key Takeaways Explain This Topic AI

Childhood absence epilepsy presents with brief, frequent staring spells with abrupt onset and offset and no postictal confusion, confirmed by generalized 3 Hz spike-and-wave discharges on EEG.

Ethosuximide is first-line for pure absence seizures; carbamazepine, oxcarbazepine, phenytoin, and vigabatrin can worsen absence seizures.

Infantile spasms (West syndrome) present as a triad of epileptic spasms, hypsarrhythmia, and developmental regression around 3-12 months, and tuberous sclerosis complex is the most common identifiable cause.

Status epilepticus treatment is time-based: a benzodiazepine at 5 minutes, a second-line agent (fosphenytoin, levetiracetam, or valproic acid) at 20 minutes, and anesthetic infusion with ICU-level care at 40 minutes.

Bedside glucose must be checked and hypoglycemia treated during initial stabilization of any seizing child, since hypoglycemic seizures will not respond to antiepileptic drugs alone.

Last updated: July 2026

Epilepsy Syndromes & Status Epilepticus

Pediatric epilepsy syndromes are defined by a cluster of typical age of onset, seizure semiology, electroencephalogram (EEG) pattern, and prognosis; the exam rewards recognizing the overall pattern rather than memorizing every possible syndrome. This section covers the syndrome tested most often on Part 1 (childhood absence epilepsy), two other syndromes you must recognize on sight (benign rolandic epilepsy and infantile spasms/West syndrome), and the time-based management of status epilepticus, one of the highest-yield algorithms on the exam.

Childhood Absence Epilepsy

Childhood absence epilepsy (CAE) typically begins between 4 and 10 years of age (peak 5-7 years) and is more common in girls. The hallmark presentation is brief, frequent staring spells:

  • Sudden onset and offset, with no aura and no warning
  • Duration of roughly 5-10 seconds
  • Behavioral arrest with a blank stare; may include subtle automatisms such as eyelid fluttering or lip smacking
  • No postictal confusion; the child resumes the prior activity immediately

Can occur dozens to hundreds of times per day, often mistaken for daydreaming or inattention and misdiagnosed as attention-deficit/hyperactivity disorder

Reliably provoked by 3 minutes of hyperventilation in clinic, a classic bedside diagnostic maneuver and a favorite exam stem

The EEG is diagnostic: generalized, bilaterally synchronous 3 Hz spike-and-wave discharges on an otherwise normal background, activated by hyperventilation.

Treatment: ethosuximide is first-line for pure absence seizures with no generalized tonic-clonic component; valproic acid is preferred if the child also has generalized tonic-clonic seizures; lamotrigine is an alternative. A classic exam trap is selecting carbamazepine, oxcarbazepine, phenytoin, gabapentin, or vigabatrin; these agents can worsen absence seizures and should be avoided.

Prognosis is generally favorable; most children outgrow CAE by adolescence, although a minority go on to develop juvenile myoclonic epilepsy or other generalized epilepsies.

Other High-Yield Pediatric Epilepsy Syndromes

Syndrome Typical age Seizure pattern EEG Prognosis

Benign rolandic epilepsy (benign epilepsy with centrotemporal spikes) 3-13 years, peak 7-10 Nocturnal focal seizures: unilateral facial or oral twitching, drooling, speech arrest; may secondarily generalize Centrotemporal spikes, activated by sleep Excellent; remits by adolescence, often needs no daily medication if seizures are infrequent

Infantile spasms (West syndrome) 3-12 months, peak about 6 months Clusters of flexor, extensor, or mixed spasms, often on waking Hypsarrhythmia: chaotic, high-voltage, disorganized background Often poor; high rate of evolution to Lennox-Gastaut syndrome and intellectual disability

Benign rolandic epilepsy is reassuring: seizures are typically brief, nocturnal, and infrequent, and the EEG abnormality dramatically out-paces the mild clinical picture, so this syndrome should not be over-treated.

Infantile spasms/West syndrome is the opposite: it is a neurologic emergency for development. The classic triad is epileptic spasms, hypsarrhythmia, and developmental regression or arrest. Any infant who stops meeting milestones or loses previously acquired skills around 6 months of age with new spasm-like movements needs an urgent EEG. Tuberous sclerosis complex is the most common identifiable structural or genetic cause and should be actively screened for on exam (hypopigmented ash-leaf macules on skin exam, cardiac rhabdomyoma on echocardiogram). Other causes include hypoxic-ischemic encephalopathy and other structural brain malformations, and many cases remain cryptogenic. First-line treatment is adrenocorticotropic hormone (ACTH) or high-dose oral corticosteroids; vigabatrin is preferred first-line specifically when tuberous sclerosis is the underlying cause, and is also used more broadly.

Status Epilepticus: The Time-Based Algorithm

Status epilepticus (SE) is operationally defined for treatment purposes as a single seizure lasting 5 minutes or longer, or recurrent seizures without return to baseline consciousness between them; the older strict definition of 30 minutes describes established status rather than the point at which treatment should begin. Every additional minute of ongoing seizure activity increases the risk of neuronal injury and treatment resistance, so the exam rewards knowing exactly which therapy belongs at which time point.

Time / line of therapy Action

0-5 minutes Stabilize: airway, breathing, and circulation; give oxygen; check bedside glucose and treat hypoglycemia; obtain intravenous (IV) access

5 minutes, first-line Benzodiazepine: IV lorazepam (0.1 mg/kg), or intramuscular (IM) midazolam (0.2 mg/kg, preferred if IV access is not yet available), or rectal diazepam. May repeat one dose if the seizure continues after about 5 minutes

20 minutes, second-line IV fosphenytoin (20 mg/kg phenytoin-equivalents), or levetiracetam (about 60 mg/kg, up to 4500 mg), or valproic acid (about 40 mg/kg)

40 minutes, third-line/refractory Repeat or combine second-line agents, or proceed to continuous anesthetic infusion (midazolam, pentobarbital, or propofol) with intubation, continuous EEG monitoring, and intensive care unit (ICU) admission

Exam traps: first, treatment should not wait for a true 30-minute mark before starting benzodiazepines; treatment starts at the 5-minute mark. Second, IM midazolam is the preferred first-line route when IV access is not immediately available, rather than delaying treatment to secure a line. Third, bedside glucose must always be checked and hypoglycemia treated as part of initial stabilization, since hypoglycemic seizures will not respond to antiepileptic drugs alone. Fourth, seizures refractory to an adequate benzodiazepine dose plus one second-line agent are termed refractory status epilepticus, and status persisting beyond 24 hours despite anesthetic-level therapy is termed super-refractory status epilepticus.